1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Sawai, M.V.
Jia, H.P.
Liu, L.
Aseyev, V.
Wiencek, J.M.
McCray Jr., P.B.
Ganz, T.
Kearney, W.R.
Tack, B.F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
40
3810
3816
10.1021/bi002519d
11300761
The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment.
2001
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4342.271
BETA-DEFENSIN-2
1
man
polymer
no
no
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
fall armyworm
sample
9606
Homo sapiens
SF21
7108
SPODOPTERA FRUGIPERDA
BACULOVIRUS
atom_site
entity_src_gen
pdbx_struct_assembly
pdbx_struct_assembly_prop
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Atomic model
Data collection
Derived calculations
Source and taxonomy
1
0
2001-04-11
1
1
2008-04-27
1
2
2011-07-13
2
0
2018-10-24
_atom_site.auth_atom_id
_atom_site.label_atom_id
_entity_src_gen.host_org_common_name
_entity_src_gen.pdbx_host_org_cell_line
_entity_src_gen.pdbx_host_org_ncbi_taxonomy_id
_entity_src_gen.pdbx_host_org_scientific_name
_entity_src_gen.pdbx_host_org_vector_type
RCSB
Y
PDBJ
2000-09-06
REL
REL
This structure was determined using standard 2D homonuclear techniques.
structures with the lowest target function value
100
20
2D NOESY,DOF-COSY,TOCSY
0.045
3.7
1013
hpa
298
K
Simulated annealing, torsion angle dynamics
1
lowest energy
0.9mM Human Beta-Defensin-2; 45mM sodium phosphate buffer
90% H2O/10% D2O
Guentert
structure solution
DYANA
1.5
Guentert
refinement
DYANA
1.5
500
Varian
INOVA
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
GLY
3
n
3
GLY
3
A
ASP
4
n
4
ASP
4
A
PRO
5
n
5
PRO
5
A
VAL
6
n
6
VAL
6
A
THR
7
n
7
THR
7
A
CYS
8
n
8
CYS
8
A
LEU
9
n
9
LEU
9
A
LYS
10
n
10
LYS
10
A
SER
11
n
11
SER
11
A
GLY
12
n
12
GLY
12
A
ALA
13
n
13
ALA
13
A
ILE
14
n
14
ILE
14
A
CYS
15
n
15
CYS
15
A
HIS
16
n
16
HIS
16
A
PRO
17
n
17
PRO
17
A
VAL
18
n
18
VAL
18
A
PHE
19
n
19
PHE
19
A
CYS
20
n
20
CYS
20
A
PRO
21
n
21
PRO
21
A
ARG
22
n
22
ARG
22
A
ARG
23
n
23
ARG
23
A
TYR
24
n
24
TYR
24
A
LYS
25
n
25
LYS
25
A
GLN
26
n
26
GLN
26
A
ILE
27
n
27
ILE
27
A
GLY
28
n
28
GLY
28
A
THR
29
n
29
THR
29
A
CYS
30
n
30
CYS
30
A
GLY
31
n
31
GLY
31
A
LEU
32
n
32
LEU
32
A
PRO
33
n
33
PRO
33
A
GLY
34
n
34
GLY
34
A
THR
35
n
35
THR
35
A
LYS
36
n
36
LYS
36
A
CYS
37
n
37
CYS
37
A
CYS
38
n
38
CYS
38
A
LYS
39
n
39
LYS
39
A
LYS
40
n
40
LYS
40
A
PRO
41
n
41
PRO
41
A
author_defined_assembly
1
monomeric
0
0
2970
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
HIS
16
A
N
HIS
16
A
O
LYS
36
A
O
LYS
36
A
O
LYS
39
A
O
LYS
39
A
N
LYS
25
A
N
LYS
25
1
A
A
O
H
VAL
LEU
6
9
1.59
1
A
A
OD2
N
ASP
THR
4
7
2.13
2
A
A
O
OG1
LEU
THR
32
35
2.03
3
A
A
H
O
ILE
CYS
14
38
1.55
3
A
A
O
H
CYS
GLY
8
12
1.60
5
A
A
O
H
VAL
LEU
6
9
1.52
5
A
A
O
H
LYS
LYS
25
39
1.53
5
A
A
OD2
H
ASP
CYS
4
8
1.56
6
A
A
HD1
O
HIS
PHE
16
19
1.53
6
A
A
O
H
LEU
GLY
9
12
1.57
6
A
A
H
O
LYS
LYS
25
39
1.57
6
A
A
O
HD2
GLY
ASP
1
4
1.58
7
A
A
H
OG1
GLY
THR
31
35
1.52
8
A
A
O
H
LEU
GLY
9
12
1.53
8
A
A
O
H
VAL
LEU
6
9
1.59
9
A
A
H
OG1
GLY
THR
31
35
1.47
10
A
A
O
H
LYS
LYS
25
39
1.58
11
A
A
H
OG1
GLY
THR
31
35
1.51
11
A
A
O
H
CYS
GLY
8
12
1.58
13
A
A
O
H
LEU
GLY
9
12
1.51
13
A
A
O
H
VAL
LEU
6
9
1.55
13
A
A
O
H
GLY
CYS
28
37
1.56
16
A
A
HD1
O
HIS
PHE
16
19
1.57
19
A
A
O
H
CYS
GLY
8
12
1.54
19
A
A
SG
SG
CYS
CYS
8
30
2.14
20
A
A
O
H
LYS
LYS
25
39
1.54
20
A
A
O
H
CYS
GLY
8
12
1.55
1
A
ILE
2
-13.45
114.59
1
A
VAL
6
-85.46
-72.88
1
A
THR
7
-38.06
-29.19
1
A
VAL
18
67.08
-76.25
1
A
ARG
22
78.54
168.31
1
A
GLN
26
-168.50
-59.03
1
A
ILE
27
86.33
41.58
1
A
CYS
30
-120.13
-56.25
1
A
THR
35
-49.94
161.91
2
A
ILE
2
2.98
103.26
2
A
VAL
18
171.77
-99.35
2
A
ARG
22
65.02
172.28
2
A
GLN
26
166.99
-68.93
2
A
ILE
27
85.66
46.95
2
A
CYS
30
-156.23
84.86
3
A
ILE
2
-17.10
112.71
3
A
SER
11
152.77
44.63
3
A
ALA
13
161.64
167.45
3
A
VAL
18
77.29
178.99
3
A
PHE
19
-42.34
169.36
3
A
ARG
22
59.22
166.88
3
A
ARG
23
-77.42
20.29
3
A
TYR
24
-58.80
-154.58
3
A
ILE
27
-173.50
23.88
3
A
THR
29
-128.12
-162.05
3
A
CYS
30
-140.51
-99.17
3
A
LEU
32
-43.76
170.87
4
A
ILE
2
-8.00
109.49
4
A
ASP
4
178.01
-177.43
4
A
VAL
6
-77.59
-71.14
4
A
VAL
18
173.55
-100.90
4
A
ARG
22
64.31
174.27
4
A
ARG
23
-69.84
12.01
4
A
GLN
26
171.08
-137.49
4
A
ILE
27
162.97
34.70
5
A
ILE
2
-10.26
111.57
5
A
VAL
6
-89.96
-74.35
5
A
THR
7
-36.24
-31.52
5
A
LYS
10
-39.41
-29.44
5
A
SER
11
153.34
43.21
5
A
ALA
13
169.59
170.77
5
A
VAL
18
36.94
-148.61
5
A
PHE
19
-39.97
162.21
5
A
ARG
22
68.12
166.06
5
A
ARG
23
-77.07
20.62
5
A
TYR
24
-71.31
-165.03
5
A
ILE
27
-170.94
21.87
5
A
CYS
30
-140.17
-96.73
5
A
LEU
32
-46.10
171.22
6
A
ILE
2
-55.50
102.05
6
A
PRO
5
-74.98
-89.97
6
A
VAL
18
173.79
-102.21
6
A
ARG
22
75.00
166.68
6
A
ARG
23
-68.56
8.96
6
A
GLN
26
177.76
-76.63
6
A
ILE
27
86.05
55.14
6
A
THR
29
-48.93
-174.75
6
A
CYS
30
-145.27
-105.61
6
A
LEU
32
-47.43
165.54
7
A
ILE
2
-28.29
106.49
7
A
VAL
6
-75.50
-71.37
7
A
THR
7
-39.24
-25.56
7
A
VAL
18
174.83
-98.62
7
A
ARG
22
74.82
173.67
7
A
GLN
26
176.59
-133.18
7
A
ILE
27
162.48
43.97
7
A
CYS
30
-144.44
-62.02
8
A
ILE
2
-38.23
158.24
8
A
VAL
6
-78.29
-71.58
8
A
VAL
18
39.59
-159.35
8
A
PHE
19
-33.86
140.46
8
A
ARG
22
66.53
160.10
8
A
ARG
23
-78.82
22.48
8
A
TYR
24
-65.85
-158.42
8
A
ILE
27
-167.73
21.96
8
A
THR
29
-129.09
-166.03
8
A
CYS
30
172.60
57.19
9
A
ILE
2
-33.21
106.56
9
A
VAL
6
-79.54
-74.50
9
A
THR
7
-38.50
-24.83
9
A
SER
11
152.66
45.68
9
A
ALA
13
168.93
167.00
9
A
VAL
18
173.65
-96.09
9
A
PHE
19
-121.26
-149.32
9
A
ARG
22
64.56
170.44
9
A
ARG
23
-77.20
21.02
9
A
TYR
24
-68.43
-165.49
9
A
ILE
27
-169.89
21.31
9
A
THR
29
-127.89
-167.10
9
A
CYS
30
-137.53
-58.62
10
A
ILE
2
-32.26
107.13
10
A
LYS
10
-38.63
-30.32
10
A
SER
11
150.87
42.78
10
A
ALA
13
169.74
161.86
10
A
VAL
18
171.95
-90.13
10
A
PHE
19
-131.09
-159.88
10
A
ARG
22
73.54
169.81
10
A
TYR
24
-68.58
-164.69
10
A
ILE
27
176.20
24.38
10
A
THR
29
-118.91
-167.98
10
A
CYS
30
-139.80
-107.84
10
A
LEU
32
-47.34
161.31
11
A
ILE
2
-13.76
115.00
11
A
VAL
6
-92.97
-64.96
11
A
LYS
10
-39.32
-30.01
11
A
SER
11
150.03
44.64
11
A
VAL
18
51.79
-155.78
11
A
PHE
19
-48.86
-178.78
11
A
ARG
22
61.55
174.66
11
A
GLN
26
-179.77
-129.24
11
A
ILE
27
163.25
53.43
11
A
CYS
30
-142.99
-67.16
11
A
THR
35
-53.35
170.56
12
A
ILE
2
-19.25
111.58
12
A
LYS
10
-35.61
-39.27
12
A
SER
11
142.90
76.95
12
A
VAL
18
39.74
-156.65
12
A
PHE
19
-35.44
154.19
12
A
ARG
22
70.35
165.60
12
A
ARG
23
-76.70
20.15
12
A
TYR
24
-69.81
-163.86
12
A
ILE
27
-171.49
24.03
12
A
THR
29
-129.82
-168.13
12
A
CYS
30
-139.59
-95.73
12
A
LEU
32
-46.36
170.23
13
A
ILE
2
-24.21
134.40
13
A
VAL
6
-78.36
-70.12
13
A
THR
7
-38.67
-27.87
13
A
VAL
18
64.86
-170.99
13
A
PHE
19
-45.89
174.57
13
A
ARG
22
65.22
160.47
13
A
TYR
24
-58.76
-149.63
13
A
GLN
26
92.25
-106.61
13
A
ILE
27
86.57
43.57
13
A
THR
29
-40.69
178.59
13
A
THR
35
-51.24
172.98
14
A
ILE
2
-23.07
127.42
14
A
VAL
18
73.84
-169.71
14
A
PHE
19
-49.02
-179.05
14
A
ARG
22
62.06
166.44
14
A
ARG
23
-77.53
21.01
14
A
TYR
24
-61.27
-154.61
14
A
ILE
27
-179.18
19.94
14
A
LEU
32
-51.57
-165.47
15
A
ILE
2
-34.43
137.55
15
A
VAL
6
-77.90
-71.99
15
A
THR
7
-39.42
-26.78
15
A
LYS
10
-39.36
-29.44
15
A
SER
11
153.27
44.33
15
A
ALA
13
171.21
170.61
15
A
VAL
18
169.26
172.87
15
A
PHE
19
-41.10
161.41
15
A
ARG
22
56.13
171.84
15
A
ARG
23
-76.79
21.02
15
A
TYR
24
-58.59
-160.51
15
A
ILE
27
-167.49
19.70
15
A
CYS
30
-106.30
-68.86
15
A
THR
35
-51.63
174.80
16
A
ILE
2
-23.50
104.17
16
A
PRO
5
-74.96
-82.56
16
A
THR
7
-37.39
-31.46
16
A
SER
11
150.96
-15.73
16
A
ALA
13
178.01
-176.63
16
A
VAL
18
173.86
-102.58
16
A
ARG
22
65.37
168.63
16
A
ARG
23
-69.57
10.60
16
A
GLN
26
164.92
-76.28
16
A
ILE
27
85.89
50.39
16
A
THR
29
-45.22
178.64
16
A
CYS
30
-131.84
-40.63
16
A
PRO
33
-75.04
49.20
16
A
THR
35
-52.68
173.62
17
A
ILE
2
-29.09
114.16
17
A
ASP
4
-174.30
-177.74
17
A
VAL
6
-83.24
-72.32
17
A
THR
7
-39.42
-28.38
17
A
SER
11
157.18
71.65
17
A
ALA
13
172.13
174.20
17
A
VAL
18
76.23
-169.80
17
A
PHE
19
-50.50
-173.87
17
A
ARG
22
60.02
166.82
17
A
ARG
23
-77.36
20.59
17
A
TYR
24
-59.49
-155.45
17
A
ILE
27
-171.81
21.58
17
A
CYS
30
-133.99
-73.35
18
A
ILE
2
47.06
170.12
18
A
VAL
18
175.59
-99.35
18
A
ARG
22
65.69
170.84
18
A
ARG
23
-77.80
21.68
18
A
TYR
24
-68.09
-164.48
18
A
ILE
27
-169.80
17.59
18
A
CYS
30
-84.71
-71.47
18
A
THR
35
-50.88
171.21
19
A
ILE
2
-7.50
101.30
19
A
VAL
6
-94.44
-61.08
19
A
ALA
13
176.16
-88.98
19
A
VAL
18
76.60
-167.59
19
A
PHE
19
-46.53
177.76
19
A
ARG
22
67.12
169.76
19
A
ARG
23
-68.77
10.92
19
A
GLN
26
171.19
-83.44
19
A
ILE
27
87.27
55.66
19
A
THR
29
-42.71
-175.85
19
A
CYS
30
-143.71
-88.71
19
A
LEU
32
-43.64
169.63
20
A
ILE
2
-23.30
128.36
20
A
LYS
10
-39.90
-29.29
20
A
SER
11
152.35
44.28
20
A
VAL
18
35.92
-150.20
20
A
PHE
19
-38.78
159.84
20
A
ARG
22
66.46
164.79
20
A
ARG
23
-76.69
20.20
20
A
TYR
24
-69.93
-164.08
20
A
ILE
27
179.93
23.03
20
A
THR
29
-122.99
-169.40
20
A
CYS
30
-139.47
-42.81
20
A
LEU
32
-46.59
177.05
HUMAN BETA-DEFENSIN-2
SOLUTION STRUCTURE OF HUMAN BETA-DEFENSIN-2
1
N
N
A
THR
7
A
THR
7
HELX_P
A
LYS
10
A
LYS
10
1
1
4
disulf
1.842
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
37
A
SG
CYS
37
1_555
disulf
2.159
A
CYS
15
A
SG
CYS
15
1_555
A
CYS
30
A
SG
CYS
30
1_555
disulf
2.013
A
CYS
20
A
SG
CYS
20
1_555
A
CYS
38
A
SG
CYS
38
1_555
ANTIBIOTIC
DEFENSIN, SOLUTION STRUCTURE, ANTIBIOTIC
BD02_HUMAN
UNP
1
24
O15263
24
64
1FQQ
1
41
O15263
A
1
1
41
3
anti-parallel
anti-parallel
A
ILE
14
A
ILE
14
A
HIS
16
A
HIS
16
A
LYS
36
A
LYS
36
A
LYS
39
A
LYS
39
A
LYS
25
A
LYS
25
A
GLY
28
A
GLY
28
1
P 1